Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developmental Approaches to Chronic Pain: A Narrative Review. | Cureus | 2023 | 37842431 | PubTator, text mining | PubMed |
| Mimicking lipolytic, adipogenic, and secretory capacities of human subcutaneous adipose tissue by spheroids from distinct subpopulations of adipose stromal/stem cells. | Front Cell Dev Biol | 2023 | 37842092 | PubTator, text mining | PubMed |
| Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream. | JID Innov | 2023 | 37840766 | PubTator, text mining | PubMed |
| Cytokines in Systemic Lupus Erythematosus-Focus on TNF-α and IL-17. | Int J Mol Sci | 2023 | 37833861 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals a peripheral landscape of immune cells in Schistosomiasis japonica. | Parasit Vectors | 2023 | 37817226 | PubTator, text mining | PubMed |
| The IL-17 family in diseases: from bench to bedside. | Signal Transduct Target Ther | 2023 | 37816755 | PubTator, text mining | PubMed |
| Global Trends in Research Regarding Macrophages Associated with Chronic Obstructive Pulmonary Disease: A Bibliometric Analysis from 2011 to 2022. | Int J Chron Obstruct Pulmon Dis | 2023 | 37810373 | PubTator, text mining | PubMed |
| Roles of four targets in the pathogenesis of graves' orbitopathy. | Heliyon | 2023 | 37810014 | PubTator, text mining | PubMed |
| Identification of biomarkers in patients with rheumatoid arthritis responsive to DMARDs but with progressive bone erosion. | Front Immunol | 2023 | 37809106 | PubTator, text mining | PubMed |
| Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases. | Front Immunol | 2023 | 37809072 | PubTator, text mining | PubMed |
| Interleukin-17 signaling influences CD8+ T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells. | Oncoimmunology | 2023 | 37808403 | PubTator, text mining | PubMed |
| Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin. | Nat Commun | 2023 | 37805522 | PubTator, text mining | PubMed |
| Identification and validation of FPR1, FPR2, IL17RA and TLR7 as immunogenic cell death related genes in osteoarthritis. | Sci Rep | 2023 | 37803031 | PubTator, text mining | PubMed |
| Individual Article: Brodalumab Is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 Update. | J Drugs Dermatol | 2023 | 37801535 | PubTator, text mining | PubMed |
| Mechanism of Action of Brodalumab May Correlate With Efficacy in Patients With Inflammatory Skin Diseases. | J Drugs Dermatol | 2023 | 37801526 | PubTator, text mining | PubMed |
| Molecular analyses of ADAMTS-1, -4, -5, and IL-17 a cytokine relationship in patients with ulcerative colitis. | BMC Gastroenterol | 2023 | 37798683 | PubTator, text mining | PubMed |
| Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome. | Blood Adv | 2023 | 37792884 | PubTator, text mining | PubMed |
| Differential molecular programs of cutaneous anaplastic large cell lymphoma and CD30-positive transformed mycosis fungoides. | Front Immunol | 2023 | 37790936 | PubTator, text mining | PubMed |
| The functional response of human monocyte-derived macrophages to serum amyloid A and Mycobacterium tuberculosis infection. | Front Immunol | 2023 | 37781389 | PubTator, text mining | PubMed |
| Therapeutic role of exosomes and conditioned medium in keloid and hypertrophic scar and possible mechanisms. | Front Physiol | 2023 | 37781228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=20